"Cost Savings" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Reductions in all or any portion of the costs of providing goods or services. Savings may be incurred by the provider or the consumer.
| Descriptor ID |
D017046
|
| MeSH Number(s) |
N03.219.151.160.200
|
| Concept/Terms |
Cost Savings- Cost Savings
- Cost Saving
- Saving, Cost
- Savings, Cost
|
Below are MeSH descriptors whose meaning is more general than "Cost Savings".
Below are MeSH descriptors whose meaning is more specific than "Cost Savings".
This graph shows the total number of publications written about "Cost Savings" by people in this website by year, and whether "Cost Savings" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 2 | 3 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 1 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cost Savings" by people in Profiles.
-
Sanogo V, Saud Almutairi RD, Diaby V. Budget impact of lecanemab for medicare beneficiaries with early Alzheimer's disease in the United States: a subgroup analysis. Expert Rev Pharmacoecon Outcomes Res. 2025 Dec; 25(10):1421-1426.
-
Mafi JN, Godoy-Travieso P, Wei E, Anders M, Amaya R, Carrillo CA, Berry JL, Sarff L, Daskivich L, Vangala S, Ladapo J, Keeler E, Damberg CL, Sarkisian C. Evaluation of an Intervention to Reduce Low-Value Preoperative Care for Patients Undergoing Cataract Surgery at a Safety-Net Health System. JAMA Intern Med. 2019 05 01; 179(5):648-657.
-
Forgione DA. Cost of Care Initiatives Make Great Strides Forward. Front Health Serv Manage. 2019; 35(3):30-34.
-
Skrundevskiy AN, Omar OS, Kim J, Soliman AS, Korolchuk TA, Wilson FA. Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries. Value Health Reg Issues. 2018 Sep; 16:22-27.
-
Chambers J, Pope E, Bungay K, Cohen J, Ciarametaro M, Dubois R, Neumann PJ. A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures. Value Health. 2018 04; 21(4):400-406.
-
Alley DE, Asomugha CN, Conway PH, Sanghavi DM. Accountable Health Communities--Addressing Social Needs through Medicare and Medicaid. N Engl J Med. 2016 Jan 07; 374(1):8-11.
-
Yamasato K, Kaneshiro B, Salcedo J. Neuraxial blockade for external cephalic version: Cost analysis. J Obstet Gynaecol Res. 2015 Jul; 41(7):1023-31.
-
Castellon YM, Bazargan-Hejazi S, Masatsugu M, Contreras R. The impact of patient assistance programs and the 340B Drug Pricing Program on medication cost. Am J Manag Care. 2014 Feb; 20(2):146-50.
-
Schwartz SM, Mason ST, Wang C, Pomana L, Hyde-Nolan ME, Carter EW. Sustained economic value of a wellness and disease prevention program: an 8-year longitudinal evaluation. Popul Health Manag. 2014 Apr; 17(2):90-9.
-
Parke DW, Coleman AL, Rich WL, Lum F. Choosing Wisely: five ideas that physicians and patients can discuss. Ophthalmology. 2013 Mar; 120(3):443-444.